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Background: eHealth applications are constantly increasing and are frequently considered to constitute a promising strategy
for cost containment in health care, particularly if the applications aim to support older persons. Older persons are, however, not
the only major eHealth stakeholder. eHealth suppliers, caregivers, funding bodies, and health authorities are also likely to attribute
value to eHealth applications, but they can differ in their value attribution because they are affected differently by eHealth costs
and benefits. Therefore, any assessment of the value of eHealth applications requires the consideration of multiple stakeholders
in a holistic and integrated manner. Such a holistic and reliable value assessment requires a profound understanding of the
application’s costs and benefits. The first step in measuring costs and benefits is identifying the relevant costs and benefit categories
that the eHealth application affects.
Objective: The aim of this study is to support the conceptual phase of an economic evaluation by providing an overview of the
relevant direct and indirect costs and benefits incorporated in economic evaluations so far.
Methods: We conducted a systematic literature search covering papers published until December 2019 by using the Embase,
Medline Ovid, Web of Science, and CINAHL EBSCOhost databases. We included papers on eHealth applications with web-based
contact possibilities between clients and health care providers (mobile health apps) and applications for self-management,
telehomecare, telemedicine, telemonitoring, telerehabilitation, and active healthy aging technologies for older persons. We
included studies that focused on any type of economic evaluation, including costs and benefit measures.
Results: We identified 55 papers with economic evaluations. These studies considered a range of different types of costs and
benefits. Costs pertained to implementation activities and operational activities related to eHealth applications. Benefits (or
consequences) could be categorized according to stakeholder groups, that is, older persons, caregivers, and health care providers.
These benefits can further be divided into stakeholder-specific outcomes and resource usage. Some cost and benefit types have
received more attention than others. For instance, patient outcomes have been predominantly captured via quality-of-life
considerations and various types of physical health status indicators. From the perspective of resource usage, a strong emphasis
has been placed on home care visits and hospital usage.
Conclusions: Economic evaluations of eHealth applications are gaining momentum, and studies have shown considerable
variation regarding the costs and benefits that they include. We contribute to the body of literature by providing a detailed and
up-to-date framework of cost and benefit categories that any interested stakeholder can use as a starting point to conduct an
economic evaluation in the context of independent living of older persons.
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Introduction
Background and Motivation
The use of information and communication technologies in
health care is regarded as an important piece of the puzzle of
increasing health care costs and demand [1], particularly if it
targets older persons with substantial health care costs [2].
Induced by an aging population that stays home longer, an
increase in self-management, and a changing role of informal
caregivers, the demand for health care delivery, and the role of
technology are changing rapidly. To contain health care costs
and maintain the quality of care and living, governments direct
policies to stimulate eHealth to increase and support
self-management [3]. In this study, eHealth is defined in line
with the description by Eysenbach [4] and the different
taxonomies described by Oh et al [5]: eHealth is at the
intersection of medical informatics, public health, and business
and offers health services to support care delivery, manage care,
promote prevention, and educate; it is delivered or enhanced
through the internet and related technologies (eg, domotics,
wearables, and sensors). In the domain of older persons living
at home, we define eHealth as web-based contact possibilities
between the clients and health care providers and applications
for self-management, telehomecare, telemedicine,
telemonitoring, and telerehabilitation.
eHealth has shown to be valuable in promoting medication
adherence and improving self-management in the population
of older persons [6]. In addition, eHealth can be used to monitor
clinical signs, collect health information, support users in
activities related to their health, and promote a healthy lifestyle
or arrange remote consultations [7-10]. Growing internet access,
increasing use of mobile apps, and current technology trends
create opportunities for novel services and new forms of health
care through eHealth [11,12]. Governments are also increasingly
funding initiatives that replace traditional care with alternatives
that use information and communication technologies to
remotely monitor and deliver health care services. Primary
funding motivation is economic in nature—promoting
preventive measures to avoid costly consequences and stimulate
efforts to increase access to care [13].
Although eHealth is frequently considered a promising
development, these applications are not without considerable
costs. eHealth equipment must be purchased, and systems must
be operated and maintained. Data recorded by eHealth should
be monitored. However, frequently, the stakeholder who benefits
from the application is not the same stakeholder who is paying
for it. Costs and benefits affect different stakeholders and
potentially also at different points in time; therefore, the
economic interests of stakeholders are often not aligned. From
the health provider perspective, such an investment does not
make an economic sense, whereas it might be highly valuable
from a societal perspective, considering the total benefits and
costs regardless of where they occur. Any assessment of the
value of an eHealth application, therefore, requires considering
multiple stakeholders in a holistic and integrated assessment of
all costs (ie, the direct and indirect and short- and long-term
costs) and all benefits (ie, the direct and indirect and short- and
long-term gains) of an eHealth application. This rationale
represents the core of economic evaluations in health care [14].
Economic evaluations in health care come in different forms
such as cost-effectiveness analyses (CEAs), cost utility analyses
(CUAs), and cost-benefit analyses (CBAs). Regardless of the
type, they have in common considering both costs and benefits,
that is, what we have to give up and what we will gain. The
main difference is the way in which gain is incorporated: CEAs
consider a one-dimensional measure of the gain, which only
allows for a comparison of programs with the same effect
measures. CUAs assess gain through utility, frequently in
quality-adjusted life years, which is comparable between health
programs. CBAs assess the gain monetarily, that is, costs and
outcomes are directly on the same scale [14,15].
Research Objective
If an interested stakeholder wants to conduct an economic
evaluation, that is, apply such an evaluation to a specific case,
he or she must first identify the relevant cost and benefit
elements. For this identification step, the body of literature can
serve as a valuable source of information. Currently, it is unclear
what types of information are available in the literature about
the relevant cost and benefit elements of eHealth. Therefore,
we conducted a scoping review to systematically map the
literature in this area and to develop an up-to-date framework
for conducting all-inclusive economic evaluations of eHealth
applications that support independent living of older persons.
Methods
Scoping Review
Our research methodology was drafted using the PRISMA
(Preferred Reporting Items for Systematic Reviews and
Meta-analysis) protocols, specifically for scoping reviews.
Among other things, scoping reviews are appropriate for
identifying key characteristics and factors related to a concept
[16]. Consequently, they lend themselves naturally to our
research objectives.
Search Query and Inclusion and Exclusion Criteria
For this study, we identified papers published until December
2019 using the Embase, Medline Ovid, Web of Science, and
CINAHL EBSCOhost databases. Additional papers were
identified by scanning the references of the identified papers
(indicated as other sources in the PRISMA flowchart in Figure
1). An experienced librarian developed search strings with some
unique features to combine search terms effectively [17,18] and
conducted the search. Our search terms are derived from the
inclusion and exclusion criteria specified later, and the complete
search query is provided in Multimedia Appendix 1.
J Med Internet Res 2021 | vol. 23 | iss. 3 | e24363 | p. 2https://www.jmir.org/2021/3/e24363
(page number not for citation purposes)
Sülz et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Figure 1. Flowchart of paper selection.
The inclusion and exclusion criteria were specified to guide the
identification process. We included original papers that were
peer reviewed, had an empirical or prescriptive nature, and were
written in English. Research protocols, commentaries, and
editorial papers were excluded from the study. We also excluded
reviews to avoid duplicate findings and avoid relying on the
review’s interpretation of the cost and benefit labels. Concerning
the patient population, we included papers that focused on
patients with an average age of at least 65 years and who were
living independently at their usual place of residence. Studies
were excluded if they considered nonolder persons (ie, infants,
adolescents, and a sample mean age younger than 65 years) or
if the patient population received care in any institutionalized
form (ie, hospitals, nursing homes, rehabilitation clinics, and
hospice). In terms of the eHealth application, we focused on
eHealth applications with web-based contact possibilities
between clients and health care providers, including mobile
health (mHealth) apps, and applications for self-management,
telehomecare, telemedicine, telemonitoring, telerehabilitation,
and active healthy aging technologies for older persons. Papers
with the following technologies were excluded: papers
describing technology not connected to the internet (eg,
implantable cardioverter defibrillator) and papers on health
information systems, electronic health records, robotics, and
telephone consults only. To obtain a comprehensive overview,
we did not use a strict definition of economic evaluation and
did not constrain our search to particular types of economic
evaluations. The only constraint on which we relied was that
economic evaluations required both costs and benefits.
Therefore, we included papers that measured at least one
monetary aspect and one benefit of eHealth applications in any
shape or form (eg, medical expenditures and analyzing clinical
effects). Papers that only described or analyzed costs at an
aggregated level or (clinical) effects were excluded.
Screening and Eligibility
Initially, 2 of the authors (SS and HE) screened a small sample
simultaneously to align the assessment. Subsequently, SS and
HE conducted abstract and title screening, with each screening
half of the identified references. The studies were labeled not
relevant or potentially relevant based on the inclusion criteria.
A random sample of the references was blindly double-checked
by AW and RH. The random set has been created by selecting
every 10th article from the set of annually ordered articles.
Interrater reliability was evaluated using the Cohen kappa (κ)
index, which is a robust statistic useful for interrater reliability
testing [19]. This double screening yielded a fair overlap
between the assessments by SS or HE and AW or RB (Cohen
κ index=0.28). After realigning the inclusion and exclusion
criteria and rescreening all of the references with previous
disagreements (conducted by AW), substantial improvements
in the alignment were achieved (Cohen κ index=0.75).
In the next screening round, SS and HE conducted the screening
based on full texts, and both authors went independently through
all of the references initially labeled as potentially relevant.
This double-blind screening yielded a substantial overlap
(Cohen κ index=0.64). SS and HE discussed all of the references
for which their assessments diverged and thus resolved
disagreements.
Data Extraction and Categorization
Two authors (SS and HE) extracted the following information
from the studies: patient population, country, type of eHealth
intervention, type of analysis that the papers report performing,
the specific cost types that the studies considered, and the
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specific benefits, gains, and consequences that the studies
included. Subsequently, we categorized the costs and benefits.
We started with 4 categories pertaining to (1) implementation
activities for the eHealth application, (2) operating and
maintenance activities for the eHealth application, (3) processes
of health care delivery, and (4) outcomes. While extracting the
information, we further refined these categories depending on
activities, stakeholders, and institutions such that the
subcategories were mutually exclusive but sufficiently broad
to capture related items.
Results
Study Selection
The search and screening processes are shown in Figure 1. The
database and manual searches resulted in 1799 papers. After
the first round of removal of duplicate papers and title and
abstract screening, the remaining 201 papers were subjected to
full-text reading. After the second step, 55 papers met our
inclusion criteria and were included in the final set for analysis.
The included references were published in the 2000-2019 time
frame, with 5 included papers from the first 5-year period
(2000-2004), 12 between 2005 and 2009, 17 between 2010 and
2014, and 21 between 2015 and 2019.
Patient Characteristics
The patient characteristics were rather broad; however, most
studies focused on chronic or cardiovascular diseases. Of the
55 references, 13 had a patient population with various chronic
health problems [13,20-31]. Cardiovascular problems received
specific attention in 17 studies [32-48]. In 10 studies, the focus
was on chronic obstructive pulmonary disease [49-58], and in
2 studies, the focus was on chronic skin problems [59,60]. Other
studies considered diabetes [61], age-related macular
degeneration [62], post-knee arthroplasty patients [63],
Parkinson disease [64], and terminal patients [65]. Five studies
did not specify any health conditions or diseases [66-70]. Of
the 55 studies, 3 focused on mental and behavioral disorders
such as anxiety [71], dementia [72], and depression [73].
Country
The studies in English were geographically clustered, with 26
studies conducted in North America, among which 20 occurred
in the United States [20-23,25-28,30,31,33,34,37,38,42,61,
62,64,67,68] and 6 in Canada [29,40,49,51,63,66]. Among the
22 studies conducted in Europe, they were spread across
countries, with 5 studies conducted in England and the United
Kingdom [24,41,43,44,53]; 3 each in Denmark [50,52,58], Italy
[32,45,55], the Netherlands [35,39,72]; 2 each in Austria [46,60]
and Germany [47,54]; and 1 each in France [59], Spain
(although not explicitly stated in the paper) [57], Norway [70],
and Sweden [69]. Finally, 4 studies took place in Australia
[36,56,71,73] and 3 in Asia, among which 2 were in Japan
[13,65] and 1 in Taiwan [48]. With the study in Taiwan being
the only one conducted in a country that is not a part of the
Organization for Economic Cooperation and Development,
there was a strong emphasis on economically strong countries
with aging populations.
Type of eHealth Interventions
The majority of included studies focused on telemonitoring or
remote monitoring involving the measurement of vital statistics
and the transmission of patient data followed by an
assessment—either automatically or manually—and triggering
action by health care professionals if required
[22-25,27-30,32-35,38-43,45-51,53,54,56,57,62,65,68,70]. In
addition, other eHealth forms included in our review related to
video consultations and virtual visits [20,21,23,30,
37,42,48,55,59,61,63,64,69]; deployment of sensor technology
to analyze behavioral patterns and wireless transmitters
[13,26,48,61,66,67,70,72]; email messaging services and web
portal access [44,69,71,73]; online disease management courses
or resources [44,71,73]; internet-delivered cognitive behavioral
therapy [71,73]; remotely supervised rehabilitation activities,
such as assistant mHealth [36,52,58]; and digital data
transmission [60]. Note that some studies blended various
eHealth forms and applications and that there was some
ambiguity in the terminology, with telehealth often being used
interchangeably with telemedicine, telemonitoring, or remote
monitoring. The specific eHealth interventions analyzed in the
studies are described in Multimedia Appendix 2 [13,20-73].
Type of Analysis
The included studies indicated various types of analysis. In total,
18 studies reported CEAs [24,25,27,34,35,39-41,44,46,
50,53,54,59,60,70,71,73], 2 studies combined CEAs with
clinical or budget impact analyses [48,62], 2 studies reported
CUAs [36,52], and 1 study reported a CBA [13]; 8 studies
denoted the evaluation as cost analysis [26,45,61,63,67-69,72],
the term cost minimization was used in 4 studies [29,49,51,65],
and 1 study reported relying on cost consequence analysis [43].
The remaining 17 studies stated that they evaluated a range of
cost and outcome measures [21,23,28,30-33,37,38,42,47,
55-58,64,66], and 2 studies relied on case studies to outline
benefits, saving, expenditures, and outcomes [20,22].
Of the 55 included studies, 8 relied on Markov modeling and
simulation models with a time frame of 1 year [40,65], 5 years
[13,34], 10 years [43,62], 20 years [35], up to 30 years [41].
Only a few studies without Markov modeling explicitly stated
the time frame of the economic evaluation, with 1 study
capturing a period of multiple weeks [63] and 6 studies with a
1-year time frame [24,39,44,45,50,54]. The remaining 40 studies
did not indicate the time frame explicitly, and the period of data
collection was, if applicable, used as a proxy for the time frame:
1-6 months [22,25,36-38,42,51,56,57,60,66], 7-12 months
[28,29,48,52,58,59,64,67-69,71-73], 13-18 months [20,21,31,
53], 19-24 months [27,49,61], and beyond 24 months
[26,30,32,33,46,47,55,70]. In 1 study, the period of data
collection was insufficiently described [23].
Specific Cost and Benefit Types
When we consider eHealth applications, what direct and indirect
costs and benefits (or consequences) might be relevant to
consider? Tables 1-3 provide an answer by outlining the
different cost and benefit types that the studies included in our
review considered. Table 1 shows the eHealth intervention costs
categorized into implementation and operating activities. Table
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2 provides an overview of the consequences of eHealth and
focuses on resource usage. Finally, Table 3 depicts eHealth
consequences in terms of outcomes categorized by stakeholder
group.





[13,22-25,29-31,35-37,39-41,44,47,50-53,55,56,59,61,63,65,66,69-73]32Device purchase (monitoring equipment, videoconferencing
equipment, etc)
[13,24,29,50,51,59,72]7License or software or initial fee purchase
[13,24,29,34,35,38,50-53,55,61,63,65,66,69,70,72]18Equipment installation
[24,25,29,35,44,50,52,53,61,70]10Training or education of operators
[30,36,40,52,63]5Technician travel time to install equipment
Operating activities
[13,24,26,28,29,35,37,39,40,43,50,51,53,55,59,65,66,68,69]18Maintenance (server, host, call center, or station)
[24,29,31,35,37,38,43,50,55,59,61,68,71-73]15Periodic fees (for licenses, insurance, etc)
[13,24,29,32,34-36,38,40,41,44,50,53,55-57,61-63,65,66,69-73]26Medical staffing: reviewing or assessing or intervening
[13,24,29,39,40,50,51,53,61,63,66,68,69,72]14Nonmedical staffing: technical support
[24]1Technician travel time to maintain equipment
J Med Internet Res 2021 | vol. 23 | iss. 3 | e24363 | p. 5https://www.jmir.org/2021/3/e24363
(page number not for citation purposes)
Sülz et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX




eHealth usage by patient
[20,22,23,25,30-32,35,37,39,44,45,51,56,61,64,70]17Televisits: number or duration of visits
Health resource usage by patient—community health services or primary care
[39,44,46,53,55,59,60,64,67]9Travel time or transportation costs (eg, for ambulance)
[24,28,31,35,39,40,44,50,52,55-57,59,68,71,73]16General practitioner: number or duration of visits
[24,44]2Walk-in center: number or duration of visits
[24,39,52,59,63]5Physiotherapist: number of sessions
[24,39]2Psychologist: number of sessions
[24,39,44,50]4Community nurse: number or duration of visits






[50,54]2Rehabilitation clinics: number or duration of admissions
[27,62,67,69,70,72]6Skilled nursing facilities: number or duration of admissions
[24,67]2Long-term care: number or duration of admission
[21,35]2Hospice: number or duration of admissions
Hospital use
[21,24,27-29,31,33,35,37-39,42,49,50,52,53,55-57,67,68]21Emergency department: number of visits
[21,24,27,28,34,35,40,43,45,46,48,50,52-54,56,59,60,62,67,68]21Outpatient clinic: number or duration of visits to specialists
[21,24,25,27-31,33,34,36-59,65-68,70,71,73]40Hospital: number or duration of admissions
[55,57]2Intensive care unit: Admissions
Drug treatment and laboratory diagnostics
[21,24,31,38,39,43,44,50,52,54,55,59,62,67,71,73]16Medication, prescriptions, or medical supplies
[66,67]3Laboratory
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Patient or client outcomes
[30,32-34,43,44,46,47,54,55,59-61,68]14Physical health status (mortality, morbidity, cardiovascular events, exac-
erbations, etc)
[22-24,66]4Psychological health status (anxiety, depression, or empowerment)
[24,35,36,39-41,44,50,52,62,71,73]12QALYsa
[24,28,33,37,38,42,47,56,61,64,66]11Quality of life (if not measured in QALYs but differently)
[31]1Setting-specific quality of care indicators
[20,23,25,29,31,40,51,66]8Satisfaction (with the device or eHealth service)
[22,28,30,37,61]5Satisfaction (in general)
[57,65,69]3Patient experience or perceived benefits
[72]1Well-being
[26]1Time spent in the usual place of residence
[30]1Transfer to a different level of care
[44,62]2Time absent from work (productivity loss or loss of income)
[43,47]2Device-related technical events
Professional caregivers
[20,25]2Satisfaction with the device
[30]1Satisfaction in general
[20,25,28,30-32,49,51,56,63,65,70]11Travel time to patient’s home
Informal caregivers




[69]1Attendance allowance (recipients receive payments to manage their own
health)
[69]1Respite care (payments made to relieve informal caregivers from providing
care)
aQALYs: quality-adjusted life years.
Level of Integration
Although Tables 1-3 provide an extensive overview of cost and
consequence aspects already considered in previous studies,
they indicate that there is diversity in how many different aspects
the studies have considered. For all the studies, we determined
whether they included at least one element of implementation
costs, operating costs, and consequences such as eHealth and
resource usage, patient outcomes, professional caregiver
outcomes, and informal caregiver outcomes. The studies had
different foci and different levels of integration, as outlined by
the diversity in Figure 2. Each study is represented by 1 bar
decomposed into the cost and consequence subcategories
considered in the study. The group of 28 studies on the left
considered at least one implementation and one operating
activity, in addition to the consequences of the eHealth
intervention [13,24,29,31,34-41,44,50,51,53,55,56,59,61,63,
65,66,69-73]. The middle group of 13 studies contains either
implementation or operating activities, in addition to
consequences [22,23,25,26,28,30,32,43,47,52,57,62,68]. Finally,
the 14 studies on the right do not consider implementation and
operating activities but only focus on the consequences
[20,21,27,33,45,46,48,49,54,58,60,64,67].
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Figure 2. Level of integration in 55 included studies (represented as bars).
Prominent and Lacking Features
Tables 1-3 also show that some components have received more
attention than others. Concentrating on the different
consequences, we observed the following: If patient outcomes
are considered, the focus lies on physical outcomes
[30,32-34,43,44,46,47,54,55,59-61,68] and quality of life or
quality-adjusted life years [24,35,36,39-41,44,50,52,62,71,73].
Productivity loss because of time absent from work received
less attention, with only 4% (2/55) of the studies incorporating
it [44,62]; however, this outcome is understandable given that
our review focused on the population of older persons, which
predominantly no longer participates in the labor market. In
terms of resource utilization, there is a strong emphasis on home
care visits, indicated by 49% (27/55) of the included studies
[21-25,28-32,34,37-39,49-51,55-57,61,64-67,69,72], and
hospital usage covered, indicated by 73% (40/55) of the included
studies [21,24,25,27-31,33,34,36-59,65-68,70,71,73]. This
outcome can be explained by many of the included studies
relying on remote monitoring or virtual visits to substitute for
home care visits or to prevent exacerbations that lead to hospital
admissions.
Comparing the consequences for professional caregivers and
informal caregivers, it becomes obvious that certain elements
are missing across all included studies. For instance, 4% (2/55)
of the included studies considered the satisfaction of professional
caregivers (in general or with the device) [20,25]; however, the
satisfaction of informal caregivers was not captured in any of
the included studies. Similarly, for professional caregivers, 20%
(11/55) of the included studies captured the travel time to
patients’ homes [20,25,28,30-32,49,51,56,63,65,70]; however,
this aspect was neglected for informal caregivers. Conversely,
for informal caregivers, emotional burden and well-being were
captured by 4% (2/55) of the included studies [66,72], whereas
none of the included studies focused on these 2 aspects for
professional caregivers.
Our final observation relates to the research and development
(R&D) costs of eHealth applications. In fact, none of the
included studies considered R&D costs, which is understandable
from the perspective that these costs have already been spent
by the time that the eHealth application is set up and running.
However, it implicitly assumes that R&D costs only occur




We conducted this review to establish a framework of costs and
benefits considered in the economic evaluations of eHealth
applications that support the independent living of older persons.
Our search identified 55 papers that conducted economic
evaluations. All of the identified papers focused on independent
living of older persons in their role as patients with one or more
chronic conditions. The identified papers considered a range of
different types of costs and benefits. Costs pertain to
implementation activities and operating activities related to
eHealth applications. Benefits (or consequences) can be
categorized according to stakeholder groups, that is, patients,
caregivers, and health care provider organizations. These
benefits can be further divided into stakeholder-specific
outcomes and resource utilization. Some cost and benefit types
have received more attention than others. For instance, patient
outcomes are predominantly captured via quality-of-life
considerations and various types of physical health status
indicators. From a resource utilization perspective, a strong
emphasis is placed on home care visits and hospital usage. One
reason for this emphasis is the frequency in which studies focus
on remote monitoring to prevent unnecessary hospital
admissions or to substitute for home care visits.
Our data extraction also revealed a set of elements that have
not been considered across all of the identified papers, including
J Med Internet Res 2021 | vol. 23 | iss. 3 | e24363 | p. 8https://www.jmir.org/2021/3/e24363
(page number not for citation purposes)
Sülz et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
travel time and satisfaction of informal caregivers, emotional
burden and well-being of professional caregivers, and last but
not least, the R&D costs of the eHealth application. The reasons
why these aspects have been neglected can be manifold: they
might have been irrelevant from the perspective from which the
economic evaluation was carried out, they might have been
unobservable because of long time lags beyond the time frame
of the evaluation, or it might have been infeasible to capture
and quantify these aspects because of methodological obstacles
or data unavailability. That the initial R&D costs of the eHealth
applications have not been considered can be justified with the
sunk cost argument—by the time that the evaluation takes place,
the R&D costs have already been spent. In this sense, the
eHealth application is considered a static technology. In the
longer run, however, the eHealth application might require an
upgrade to comply with new laws and regulations, for reasons
pertaining to data privacy, data security, data storage, or
improvements in usability. Whether these upgrade costs are
indeed relevant for future economic evaluations depends on the
perspective and time frame.
Like any other technology, eHealth applications are subject to
change. Fueled by the increasing availability of data, changes
in law and regulations and improved usability, new fields, and
areas of applications might emerge. Our framework is based on
eHealth applications currently in place. Future eHealth
applications might generate costs and benefits that are different
from the eHealth applications on which our framework is based.
Implications for Research and Practice
Economic evaluations of eHealth applications are gaining
momentum, as indicated by the increasing number of
publications and reviews [74,75]. Health economic frameworks
and principles are described, and the steps to measure costs and
benefits are emphasized [14,15]. Our review directly connects
to the measurement aspect by focusing on its first step, that is,
the identification of costs and benefits. We contribute to the
body of literature by providing a detailed and up-to-date
framework of cost and benefit categories.
If we consider eHealth, there are many stakeholders involved,
such as patients, eHealth suppliers (formal and informal)
caregivers, funding bodies, health authorities, and so on.
Notably, these stakeholders are likely to attribute different values
to eHealth applications because they are affected differently by
their costs and benefits. This fact has consequences for
investment and funding decisions, and it has long been argued
that decision making remains hampered by the lack of reliable
cost and benefit estimations [14,15]. To obtain reliable cost and
benefit estimates, our framework could be of help by providing
a starting point for the identification process. Our framework
can support this goal; however, the measuring and valuing
process must be context-specific and tailored to the case at hand.
How to value components that, for instance, do not lend
themselves naturally to being quantified in countable units, such
as the feeling of safety [76], is worthy of study in itself and
beyond the scope of our review. The variety that we observe in
terms of costs and consequences considered in the economic
evaluations and the type of analysis performed and the extent
to which the costs and consequences are integrated indicates
that the field has not yet reached consensus on a standard
procedure for determining eHealth value. Whether and to what
extent the observed variety is actually linked to the quality of
the economic evaluation is an interesting avenue for future
research.
Financial costs directed to patients or informal caregivers might
be an obstacle to using the eHealth service or application or
continuation of usage of these services, especially in countries
where mandatory health insurance coverage is lacking. Although
a recent study in the Netherlands identified finance as a factor
not significantly related to intention to use medical apps among
older persons [77], future studies should focus on how the costs
are covered and who should pay for the direct or indirect costs
of eHealth.
Conclusions
A holistic and reliable value assessment of eHealth applications
requires a profound understanding of the applications’ costs
and benefits. The first step in measuring costs and benefits is
identifying the relevant costs and benefit categories that the
eHealth application affects. We conduct a scoping review to
support this identification process by providing an overview of
the direct and indirect costs and benefits that economic
evaluations have incorporated so far. Our cost-and-benefit
framework is particularly useful in the context of eHealth
applications that support the independent living of older persons.
As this patient group is expected to be increasingly targeted to
contain health care costs, expanding the scope of eHealth
applications to broader populations, rather than only diagnosed
patient groups, and assessing the value of eHealth technologies
are of the utmost importance for making well-informed
investment and funding decisions.
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